STOCK TITAN

[SCHEDULE 13G/A] Roivant Sciences Ltd. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

Roivant Sciences (ROIV) disclosure shows a group of Viking Global entities and three executive committee members collectively beneficially own 34,237,779 Common Shares, representing 5.02% of the 682,229,832 shares outstanding reported by the issuer.

The filing (Schedule 13G, Amendment No. 5) lists each reporting person and the number of shares for which they have shared voting and dispositive power (VGI: 34,237,779; VGP: 18,346,865; VGEM: 17,979,927; VLFM: 6,384,710; VGOP: 9,506,204; VGEII: 366,938). The reporting persons state the securities were not acquired to change or influence control of the issuer.

Roivant Sciences (ROIV) ha rivelato che un gruppo di entità Viking Global e tre membri del comitato esecutivo posseggono collettivamente 34.237.779 azioni ordinarie, pari al 5,02% delle 682.229.832 azioni in circolazione segnalate dall'emittente.

La comunicazione (Schedule 13G, Emendamento n. 5) elenca ciascun soggetto segnalante e il numero di azioni su cui detiene potere congiunto di voto e di disposizione (VGI: 34.237.779; VGP: 18.346.865; VGEM: 17.979.927; VLFM: 6.384.710; VGOP: 9.506.204; VGEII: 366.938). I soggetti dichiarano che i titoli non sono stati acquistati con l'intento di modificare o influenzare il controllo dell'emittente.

Roivant Sciences (ROIV) informó que un grupo de entidades de Viking Global y tres miembros del comité ejecutivo poseen colectivamente 34.237.779 acciones ordinarias, lo que representa el 5,02% de las 682.229.832 acciones en circulación reportadas por el emisor.

La presentación (Schedule 13G, Enmienda n.º 5) detalla a cada persona informante y el número de acciones sobre las que tienen poder conjunto de voto y disposición (VGI: 34.237.779; VGP: 18.346.865; VGEM: 17.979.927; VLFM: 6.384.710; VGOP: 9.506.204; VGEII: 366.938). Las personas informantes indican que los valores no se adquirieron con la intención de cambiar o influir en el control del emisor.

Roivant Sciences (ROIV) 공시는 Viking Global 계열사들과 세 명의 집행위원회 위원들이 함께 34,237,779 보통주를 보유하고 있으며, 이는 발행사가 보고한 총 682,229,832주 가운데 5.02%에 해당한다고 밝혔습니다.

해당 제출서(Schedule 13G, 수정서 제5호)는 각 보고인과 그들이 공동 의결권 및 처분권을 가진 주식 수를 기재하고 있습니다(VGI: 34,237,779; VGP: 18,346,865; VGEM: 17,979,927; VLFM: 6,384,710; VGOP: 9,506,204; VGEII: 366,938). 보고인들은 해당 증권들이 발행사의 지배권을 변경하거나 영향력을 행사하기 위해 취득된 것이 아니라고 명시했습니다.

Roivant Sciences (ROIV) déclare qu'un groupe d'entités Viking Global et trois membres du comité exécutif détiennent collectivement 34 237 779 actions ordinaires, soit 5,02 % des 682 229 832 actions en circulation déclarées par l'émetteur.

Le dépôt (Schedule 13G, Amendement n°5) énumère chaque personne déclarante et le nombre d'actions pour lesquelles elles exercent un pouvoir conjoint de vote et de disposition (VGI : 34 237 779 ; VGP : 18 346 865 ; VGEM : 17 979 927 ; VLFM : 6 384 710 ; VGOP : 9 506 204 ; VGEII : 366 938). Les déclarants indiquent que ces titres n'ont pas été acquis dans le but de modifier ou d'influencer le contrôle de l'émetteur.

Roivant Sciences (ROIV) legt offen, dass eine Gruppe von Viking Global-Einheiten und drei Mitglieder des Exekutivausschusses gemeinsam 34.237.779 Stammaktien halten, was 5,02% der 682.229.832 ausstehenden Aktien ausmacht, die vom Emittenten gemeldet wurden.

Die Einreichung (Schedule 13G, Änderung Nr. 5) führt jede meldende Person und die Anzahl der Aktien auf, über die sie gemeinsame Stimm- und Verfügungsgewalt haben (VGI: 34.237.779; VGP: 18.346.865; VGEM: 17.979.927; VLFM: 6.384.710; VGOP: 9.506.204; VGEII: 366.938). Die meldenden Personen geben an, dass die Wertpapiere nicht erworben wurden, um die Kontrolle über den Emittenten zu ändern oder zu beeinflussen.

Positive
  • Clear disclosure of total beneficial ownership: 34,237,779 Common Shares (5.02%).
  • Detailed breakdown by affiliated entities: specific shared voting and dispositive power amounts for each reporting person are provided.
  • Certification of passive intent: reporting persons state securities were not acquired to change or influence control of the issuer.
Negative
  • None.

Insights

TL;DR: Viking Global and related funds report a disclosed beneficial stake of 5.02% in Roivant, with shared voting and dispositive authority.

The Schedule 13G/A identifies a coordinated group of Viking Global entities and three named individuals that may be deemed to beneficially own 34,237,779 shares, equal to 5.02% of outstanding common shares (basis: 682,229,832). The filing breaks down shared voting and dispositive power by entity, reflecting fund structures where general partners, managers and master funds hold authority over portfolio positions. The statement also includes the required certification that the position was not acquired to influence control, consistent with passive investor reporting.

TL;DR: Ownership is concentrated across affiliated funds with shared authority; governance implications center on coordinated voting power.

The document shows no sole voting or dispositive power held by any single reporting person; instead, shared voting and disposition are reported across multiple Viking entities and three executive committee members. This structure indicates centralized decision-making through affiliated management and highlights that collective influence is exercised via shared authority rather than direct sole control. The filing includes a joint filing agreement as an exhibit, confirming coordinated disclosure among the reporting persons.

Roivant Sciences (ROIV) ha rivelato che un gruppo di entità Viking Global e tre membri del comitato esecutivo posseggono collettivamente 34.237.779 azioni ordinarie, pari al 5,02% delle 682.229.832 azioni in circolazione segnalate dall'emittente.

La comunicazione (Schedule 13G, Emendamento n. 5) elenca ciascun soggetto segnalante e il numero di azioni su cui detiene potere congiunto di voto e di disposizione (VGI: 34.237.779; VGP: 18.346.865; VGEM: 17.979.927; VLFM: 6.384.710; VGOP: 9.506.204; VGEII: 366.938). I soggetti dichiarano che i titoli non sono stati acquistati con l'intento di modificare o influenzare il controllo dell'emittente.

Roivant Sciences (ROIV) informó que un grupo de entidades de Viking Global y tres miembros del comité ejecutivo poseen colectivamente 34.237.779 acciones ordinarias, lo que representa el 5,02% de las 682.229.832 acciones en circulación reportadas por el emisor.

La presentación (Schedule 13G, Enmienda n.º 5) detalla a cada persona informante y el número de acciones sobre las que tienen poder conjunto de voto y disposición (VGI: 34.237.779; VGP: 18.346.865; VGEM: 17.979.927; VLFM: 6.384.710; VGOP: 9.506.204; VGEII: 366.938). Las personas informantes indican que los valores no se adquirieron con la intención de cambiar o influir en el control del emisor.

Roivant Sciences (ROIV) 공시는 Viking Global 계열사들과 세 명의 집행위원회 위원들이 함께 34,237,779 보통주를 보유하고 있으며, 이는 발행사가 보고한 총 682,229,832주 가운데 5.02%에 해당한다고 밝혔습니다.

해당 제출서(Schedule 13G, 수정서 제5호)는 각 보고인과 그들이 공동 의결권 및 처분권을 가진 주식 수를 기재하고 있습니다(VGI: 34,237,779; VGP: 18,346,865; VGEM: 17,979,927; VLFM: 6,384,710; VGOP: 9,506,204; VGEII: 366,938). 보고인들은 해당 증권들이 발행사의 지배권을 변경하거나 영향력을 행사하기 위해 취득된 것이 아니라고 명시했습니다.

Roivant Sciences (ROIV) déclare qu'un groupe d'entités Viking Global et trois membres du comité exécutif détiennent collectivement 34 237 779 actions ordinaires, soit 5,02 % des 682 229 832 actions en circulation déclarées par l'émetteur.

Le dépôt (Schedule 13G, Amendement n°5) énumère chaque personne déclarante et le nombre d'actions pour lesquelles elles exercent un pouvoir conjoint de vote et de disposition (VGI : 34 237 779 ; VGP : 18 346 865 ; VGEM : 17 979 927 ; VLFM : 6 384 710 ; VGOP : 9 506 204 ; VGEII : 366 938). Les déclarants indiquent que ces titres n'ont pas été acquis dans le but de modifier ou d'influencer le contrôle de l'émetteur.

Roivant Sciences (ROIV) legt offen, dass eine Gruppe von Viking Global-Einheiten und drei Mitglieder des Exekutivausschusses gemeinsam 34.237.779 Stammaktien halten, was 5,02% der 682.229.832 ausstehenden Aktien ausmacht, die vom Emittenten gemeldet wurden.

Die Einreichung (Schedule 13G, Änderung Nr. 5) führt jede meldende Person und die Anzahl der Aktien auf, über die sie gemeinsame Stimm- und Verfügungsgewalt haben (VGI: 34.237.779; VGP: 18.346.865; VGEM: 17.979.927; VLFM: 6.384.710; VGOP: 9.506.204; VGEII: 366.938). Die meldenden Personen geben an, dass die Wertpapiere nicht erworben wurden, um die Kontrolle über den Emittenten zu ändern oder zu beeinflussen.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G



VIKING GLOBAL INVESTORS LP
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of Viking Global Investors LP (1)(2)(3)
Date:08/14/2025
VIKING GLOBAL PERFORMANCE LLC
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of Viking Global Performance LLC (1)(2)(3)
Date:08/14/2025
Viking Global Equities II LP
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of Viking Global Equities II LP (1)(2)(3)
Date:08/14/2025
Viking Global Equities Master Ltd.
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of Viking Global Equities Master Ltd. (1)(2)(3)
Date:08/14/2025
Viking Long Fund GP LLC
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of Viking Long Fund GP LLC (1)(2)(3)
Date:08/14/2025
Viking Long Fund Master Ltd.
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of Viking Long Fund Master Ltd. (1)(2)(3)
Date:08/14/2025
Viking Global Opportunities Parent GP LLC
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of Viking Global Opportunities Parent GP LLC (1)(2)(3)
Date:08/14/2025
Viking Global Opportunities GP LLC
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of Viking Global Opportunities GP LLC (1)(2)(3)
Date:08/14/2025
Viking Global Opportunities Portfolio GP LLC
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of Viking Global Opportunities Portfolio GP LLC (1)(2)(3)
Date:08/14/2025
Viking Global Opportunities Illiquid Investments Sub-Master LP
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of Viking Global Opportunities Illiquid Investments Sub-Master LP (1)(2)(3)
Date:08/14/2025
HALVORSEN OLE ANDREAS
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of O. Andreas Halvorsen (1)
Date:08/14/2025
Ott David C.
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of David C. Ott (2)
Date:08/14/2025
Shabet Rose Sharon
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of Rose S. Shabet (3)
Date:08/14/2025

Comments accompanying signature: (1) Scott M. Hendler is signing on behalf of O. Andreas Halvorsen, individually and as an Executive Committee Member of VIKING GLOBAL PARTNERS LLC, on behalf of VIKING GLOBAL INVESTORS LP, and as an Executive Committee Member of VIKING GLOBAL PERFORMANCE LLC, on behalf of itself and VIKING GLOBAL EQUITIES II LP and VIKING GLOBAL EQUITIES MASTER LTD., and as an Executive Committee Member of VIKING LONG FUND GP LLC, on behalf of itself and VIKING LONG FUND MASTER LTD., and as an Executive Committee Member of VIKING GLOBAL OPPORTUNITIES PARENT GP LLC, on behalf of itself and VIKING GLOBAL OPPORTUNITIES GP LLC, VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC, and VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP, pursuant to an authorization and designation letter dated February 9, 2021, which was previously filed with the Commission as an exhibit to a Form 13G filed by Mr. Halvorsen on February 12, 2021 (SEC File No. 005-49737). (2) Scott M. Hendler is signing on behalf of David C. Ott, individually and as an Executive Committee Member of VIKING GLOBAL PARTNERS LLC, on behalf of VIKING GLOBAL INVESTORS LP, and as an Executive Committee Member of VIKING GLOBAL PERFORMANCE LLC, on behalf of itself and VIKING GLOBAL EQUITIES II LP and VIKING GLOBAL EQUITIES MASTER LTD., and as an Executive Committee Member of VIKING LONG FUND GP LLC, on behalf of itself and VIKING LONG FUND MASTER LTD., and as an Executive Committee Member of VIKING GLOBAL OPPORTUNITIES PARENT GP LLC, on behalf of itself and VIKING GLOBAL OPPORTUNITIES GP LLC, VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC, and VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP, pursuant to an authorization and designation letter dated February 9, 2021, which was previously filed with the Commission as an exhibit to a Form 13G filed by Mr. Ott on February 12, 2021 (SEC File No. 005-49737). (3) Scott M. Hendler is signing on behalf of Rose S. Shabet, individually and as an Executive Committee Member of VIKING GLOBAL PARTNERS LLC, on behalf of VIKING GLOBAL INVESTORS LP, and as an Executive Committee Member of VIKING GLOBAL PERFORMANCE LLC, on behalf of itself and VIKING GLOBAL EQUITIES II LP and VIKING GLOBAL EQUITIES MASTER LTD., and as an Executive Committee Member of VIKING LONG FUND GP LLC, on behalf of itself and VIKING LONG FUND MASTER LTD., and as an Executive Committee Member of VIKING GLOBAL OPPORTUNITIES PARENT GP LLC, on behalf of itself and VIKING GLOBAL OPPORTUNITIES GP LLC, VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC, and VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP, pursuant to an authorization and designation letter dated February 9, 2021, which was previously filed with the Commission as an exhibit to a Form 13G filed by Ms. Shabet on February 12, 2021 (SEC File No. 005-49737).
Exhibit Information

EXHIBIT A - JOINT FILING AGREEMENT

FAQ

How many Roivant (ROIV) shares does Viking Global beneficially own?

The reporting persons collectively beneficially own 34,237,779 Common Shares of Roivant, representing 5.02% of the class.

What percentage of Roivant outstanding shares does the filing use as the basis?

Percentages are based on 682,229,832 Common Shares outstanding as reported by the issuer.

Do any reporting persons claim sole voting or dispositive power over the shares?

No. The filing reports 0 shares as sole voting or sole dispositive power for each reporting person; voting and dispositive powers are reported as shared.

Was the position acquired to influence control of Roivant?

The filing includes a certification stating the securities were not acquired and are not held for the purpose of changing or influencing control of the issuer.

Which Viking entities hold the largest shares and shared voting power in Roivant?

Key holders with shared voting/dispositive power include VGI (34,237,779), VGEM (17,979,927), and VGP (18,346,865), among others listed in the filing.
Roivant Sciences

NASDAQ:ROIV

ROIV Rankings

ROIV Latest News

ROIV Latest SEC Filings

ROIV Stock Data

8.09B
428.86M
24.36%
83.46%
6.21%
Biotechnology
Pharmaceutical Preparations
Link
United Kingdom
LONDON